-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Benitec Biopharma Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Sep 2019 to 30 Sep 2025.
- Benitec Biopharma Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
- Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $70,485,000, a 3.6% increase from 2024.
- Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $68,029,000, a 325% increase from 2023.
- Benitec Biopharma Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $16,015,000.